BioSpace News Archive

April 9, 2020 12:00 UTC New Merck for Mothers Commitment Adds to Merck’s Overall Support to Global, National and Local COVID-19 Relief Efforts KENILWORTH, N.J.--( BUSINESS WIRE )-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today a commitment to strengthen health systems affected by the COVID-19 pandemic. Through Merck for Mothers, the company’s global initiative to help end preventable maternal deaths, the company will provide $3 millio

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it has been granted Brazil Patent No. BR112013028296-7, titled, METHODS FOR DETECTING NUCLEIC ACID SEQUENCE VARIANTS.

Financing will support i20 Therapeutics’ growth and R&D of platform for oral delivery of injectable biologic drugs

Riptide Bioscience, Inc., today announced that Dame Carol M. Black, FRCP, MACP, FMedSci, Foreign Associate Member of the Institute of Medicine USA, renowned clinician/scientist and eminent expert in systemic sclerosis, has joined the company’s Scientific Advisory Board (SAB).

DiaCarta Inc, a precision molecular diagnostic company in CA, announced Thursday the US FDA granted Emergency Use Authorization for DiaCarta’s proprietary QuantiVirus™ PCR diagnostic (Dx) test specifically detecting three different genes of SARS-CoV-2, the virus causing the COVID-19 pandemic. DiaCarta recently expanded manufacturing capacity to 500,000 tests per week and is planning to expand to even larger (4x) scale m

Sangamo has received $225 million in stock proceeds; will receive additional $125 million upfront license fee by May 8, 2020

Vicromax shown to decrease viral production of Covid -19 coronavirus by over 98% Article highlights recent work done in laboratory studies of Covid -19 with Vicromax(tm) at the Galveston Lational Laboratory at The University of Texas Medical Branch BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform, today announce

Research to evaluate whether combination treatments of antimalarial drugs and antibiotics decrease respiratory symptoms for COVID-19 patients

Tenax Therapeutics, Inc. today announced that the last patient has completed their final visit in the Company’s Phase 2 clinical trial of levosimendan in patient

Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus” or the “Company”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents announced today that its preliminary unaudited revenue for the fiscal first quarter ended March 31, 2020 will be near the top end of previously disclosed guidance range issued on Februar